Antimalarial Drugs Supply Disrupted Due To Covid-19 Pandemic

Mumbai : A new study has found that patients with rheumatic diseases in Africa and Southeast Asia, the Americas, and Europe, are facing difficulty to secure hydroxychloroquine — highly vouched…

SEC Asks DCGI To Dig Out Details About ‘Side-Effects’ Of HCQ

New Delhi : The Narendra Modi government has recommended to the Central Drugs Standard Control Organisation (CDSCO), the country’s apex health regulatory body, to find out more details about the…

Anti-parasitic drug ivermectin not to be included for Covid-19 treatment protocol: Health Ministry

New Delhi: The Union Health Ministry has decided not to include ivermectin medicine (anti-parasitic drug) in the National Clinical Management Protocol for Covid-19 for the treatment of virus-infected patients. The move comes after the Central government’s…

IIIT Delhi develops Artificial Intelligence Model for COVID

New Delhi: In a bid to counter the Coronavirus pandemic that has been rampaging around the world, IIIT Delhi has worked on computational AI (Artificial Intelligence) model for drug repositioning…